Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02338492 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A NA study, sponsored by IlluminOss Medical.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT02338492: Completed NA study, sponsored by IlluminOss Medical.
NCT02338492 is a NA study that has completed, run by IlluminOss Medical. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02338492, a NA study, has completed, sponsored by IlluminOss Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study will collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of fractures of the humerus secondary to metastatic cancer.
Primary Outcome
Change in VAS score from baseline. VAS is measured on a scale range from 0-100mm with 0 (no pain) to 100 (worst imaginable pain).
Interventions
- DEVICE Photodynamic Bone Stabilization System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02338492 record still lists
NCT02338492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Photodynamic Bone Stabilization System is the first listed.
NCT02338492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02338492 about?
NCT02338492 is a clinical study titled "Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus". This study will collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of fractures of the humerus secondary to metastatic cancer.
What is the current status of trial NCT02338492?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2015-03. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02338492?
The interventions under investigation include: Photodynamic Bone Stabilization System (DEVICE).
Who is sponsoring clinical trial NCT02338492?
This trial is sponsored by IlluminOss Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02338492's enrollment target sits among peer trials
81 992nd of 2000 higher than 1,007 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia